The Tandem Mobi Insulin pump is small enough to be worn almost anywhere, including a coin pocket, providing users with more discretion, comfort, and options for how they manage their diabetes. Powered by Control-IQ technology, which has demonstrated in real-world studies improved time in range overnight and during the day4, Tandem Mobi connects with Dexcom G7 or Dexcom G6 to predict glucose levels 30 minutes in advance and automatically adjusts insulin, if needed, to help prevent highs and lows.

The certification allows TOOsonix to sell its flagship product, System ONE-M™, across the European Economic Area. Treatment of skin cancer and skin diseases can now be conducted in ways never before possible, providing more patient-friendly treatment than traditional procedures.

Ceretrieve notes their aspiration catheter demonstrated clots removal, completely restoring blood flow in a single pass.

“We are very excited to bring PathKeeper Surgical to the Vizient Innovative Technology Exchange,” said Erez Lampert, CEO of PathKeeper. “Our mission is to revolutionize the spine surgical landscape by integrating advanced technologies that prioritize patient safety and surgical precision. Our advancement significantly enhances surgical workflows and reduces radiation exposure, benefiting both patients and medical professionals. We are excited to bring our innovative solution to market with Vizient, where it can make a real difference in diverse surgical settings, democratizing technology for spine surgeons and patients everywhere.”